 The drug being tested in this study is called TAK-137. TAK-137 is being tested to find a safe and well-tolerated dose. This study looked at safety lab results and side effects and pharmacokinetic properties drug absorption, distribution, metabolism, and excretion in people who took TAK-137. This study was designed as a single ascending 6 Cohort dose study with planned doses of 2, 5, 15, 50, and 100 mg and Cohort 6 dose to be determined if the maximum tolerated dose MTD was not reached. Anticipated enrollment was 48. 